Doctors Scale Prison Walls To Help Women At Risk For AIDS Stay Out Of Jail

July 02, 1998

PROVIDENCE, R.I. - With more than one-third of the Rhode Island's HIV-infected women first diagnosed behind bars, the prison system has become a key place to prevent HIV infection and to treat women at risk for AIDS. Medical care can make a difference, according to infectious disease specialist Tim Flanigan, M.D., and his colleagues at Brown University and Miriam Hospital. In fact, women who saw the same doctor for at least two years were more likely to stay out of jail than those who did not have a regular doctor, according to a study of 1,148 women infected with HIV or at high risk for HIV infection in Providence, Baltimore, New York and Detroit, even when counting drug use and prior prison time, according to a study by Flanigan and others.

Acting on that knowledge can slow down the cycle of incarceration, release and reincarceration for women in some inner-city neighborhoods, according to other reports. In two Rhode Island interventions, short-term recidivism rates dropped by half for women who received continuous medical care from inside jail walls to outside, says Flanigan, who directs one of the first programs in the country to provide HIV-infected inmates with continuous health care during and after incarceration. In the Rhode Island studies, the 48 women with HIV and 73 women at high risk for HIV also received counseling and referrals for substance abuse, financial resources, social support and housing.

"Medical care probably provides a gateway to substance abuse help, treatment of mental health diseases such as depression, fallout from prior sexual abuse, and referral for case management of issues such as homelessness," says Flanigan. "But it's more than that. Having the same caregiver or physician gives women a sense of hope, of care and of concern, which many have never had. It's emotional support in a medical context, which can be very powerful in helping them to change their lives."

Media Contacts:
Tim Flanigan M.D., (401) 793-7152 or 785-5056 (beeper).
-end-


Brown University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.